Get the full picture
Sign in to uncover key details.
Show More
ImmunoGenesis
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd Ste J, Houston, Texas...Phone Number
(346) 772-0336Website
www.immunogenesis.comRevenue
$5 MillionIndustry
About ImmunoGenesis
ImmunoGenesis is focused on developing next-generation immunotherapies aimed at treating 'cold' cancers that are resistant to current immunotherapy options. Their lead molecule, IMGS-001, is designed to dismantle barriers preventing T cells from attacking tumors, while additional products like IMGS-101 and IMGS-203 target specific challenges in the tumor microenvironment. The company aims to redefine treatable cancers and expand the population benefiting from immunotherapy, addressing a significant unmet need in the oncology market. With ongoing clinical trials and a commitment to innovative drug design, ImmunoGenesis is positioned to lead the next wave of immunotherapy advancements.Explore more
ImmunoGenesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to ImmunoGenesis
Compare insights from companies similar to ImmunoGenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ImmunoGenesis Tech Stack
A closer look at the technologies used by ImmunoGenesis
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ImmunoGenesis
Sign Up For FreeTo access detailed company insights
ImmunoGenesis is focused on developing next-generation immunotherapies aimed at treating 'cold' cancers that are resistant to current immunotherapy options. Their lead molecule, IMGS-001, is designed to dismantle barriers preventing T cells from attacking tumors, while additional products like IMGS-101 and IMGS-203 target specific challenges in the... Read More
